NCT00797472 Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease Status UNKNOWN Phase PHASE2
NCT00796991 Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine Status COMPLETED Phase PHASE1
NCT00793897 Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT00792558 Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers Status WITHDRAWN Phase PHASE1
NCT00790010 Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma Status COMPLETED Phase PHASE1
NCT00789581 A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer Status COMPLETED Phase PHASE3
NCT00788333 Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00787267 Phase II Study of Dasatinib in Previously Treated Patients With Advanced NSCLC Status TERMINATED Phase PHASE2
NCT00787150 A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation Status COMPLETED Phase PHASE2
NCT00785954 Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack] Status COMPLETED Phase PHASE2
NCT00784459 The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics Status COMPLETED Phase PHASE2
NCT00780676 Personalized Treatment Selection for Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00780000 Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer Status TERMINATED Phase PHASE2
NCT00779428 Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating Tanespimycin Status COMPLETED Phase PHASE2
NCT00778622 Body Weight Effects on Glucophage's Efficacy in Chinese Diagnosed T2DM Patients Status COMPLETED Phase PHASE4
NCT00777036 A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib Status COMPLETED Phase PHASE2
NCT00773344 Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin Status COMPLETED Phase PHASE1/PHASE2
NCT00770302 Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin Status COMPLETED Phase PHASE1